The people gathered in the banquet room were there to support two families who – I’m sure – don’t’ really care who is ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...